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Introduction
Lamotrigine (LTG), an aromatic antiepileptic drug, is
mainly used to manage epilepsy and bipolar / mood dis-
orders. Skin rashes are the most common adverse reac-
tion to this drug that typically develop in the first 8
weeks of treatment.
Case presentation
A 27-year-old Caucasian woman treated with LTG 25 mg
PO for a depressive episode was hospitalized in our
allergy clinic with highly pruritic maculopapular eruption
(MPE), affecting her abdomen, chest, back and forearms,
which had started 2 days earlier along with fever of
37.5ºC. A well-defined red dermographism and tender-
ness of the skin was observed. She had been prescribed
LTG 8 days before the symptoms commenced. A LTG-
induced drug rash was suspected and the offending drug
was therefore withdrawn.
The patient was prescribed methylprednisolone 60
mg/d IV, bilastine 2x20 mg/d PO, and chloropyramine
25 mg IM in the evening. Topical skin care with emolli-
ents was started, as well.
All blood and urine laboratory tests were within reference
ranges except for the hsCRP of 9.6 mg/l (reference values
up to 5 mg/l). Abdominal ultrasonography was performed
and was unremarkable. The lesions subsided 7 days after
starting the treatment. The patient was discharged with a
prescription for methylprednisolone 20 mg/d PO, bilastine
20 mg/d PO and topical emollient skin care.
13 days later a new flare-up of MPE occurred. Again,
laboratory tests were normal. The patient was prescribed
methylprednisolone 40 mg/d IV, bilastine 2x20 mg/d PO
and emollients. The eruption sustained for 3 weeks with
frequent flare-ups. The corticosteroids’ regimen was
adapted promptly with step downs and ups in order to
maintain the severity of the symptoms. Antihistamines
and emollients helped releive the subjective symptoms.
Conclusion
MPE due to LTG is a common drug-induced hypersen-
sitivity reaction. This reaction is generally mild. How-
ever, reactions should be monitored closely as they can
be refractory and relapsing. This case presentation pro-
vides evidence that challenge tests should be performed
at least 2 months after the discontinuation of the sus-
pected drug, for there is a risk of false-positive reactions
due to subsiding flare-ups.
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